XML 43 R31.htm IDEA: XBRL DOCUMENT
v3.21.2

Organization and Description of Business (Details) - USD ($) |  | 1 Months Ended | 6 Months Ended | 12 Months Ended |
--- | --- | --- | --- | --- | ---
Aug. 01, 2018 | Aug. 31, 2020 | Jul. 31, 2021 | Jul. 31, 2020 | Jan. 31, 2021 | Jan. 31, 2020 | Jun. 25, 2019
Organization and Description of Business (Details) [Line Items] |  |  |  |  |  |  |
Converted per share (in Dollars per share) |  |  |  |  |  |  | $ 0.25
Goodwill (in Dollars) |  | $ 5,810,640 | $ 7,529,875 |  | $ 7,529,875 | $ 1,719,235 |
Potential shares of common stock (in Shares) |  |  | 141,830 | 141,830 | 141,830 | 70,000 |
Derivative liability (in Dollars) |  |  |  |  | $ 0 | $ 928,774 |
Three Customers [Member] | Revenue Benchmark [Member] |  |  |  |  |  |  |
Organization and Description of Business (Details) [Line Items] |  |  |  |  |  |  |
Concentration risk percentage |  |  |  |  |  | 100.00% |
Two Customer [Member] |  |  |  |  |  |  |
Organization and Description of Business (Details) [Line Items] |  |  |  |  |  |  |
Concentration risk percentage |  |  |  |  | 67.00% |  |
Two Customer [Member] | Accounts Receivable [Member] |  |  |  |  |  |  |
Organization and Description of Business (Details) [Line Items] |  |  |  |  |  |  |
Concentration risk percentage |  |  |  |  | 13.00% | 100.00% |
One Customer [Member] | Revenue Benchmark [Member] |  |  |  |  |  |  |
Organization and Description of Business (Details) [Line Items] |  |  |  |  |  |  |
Concentration risk percentage |  |  |  |  | 62.00% |  |
4P Therapeutics LLC [Member] |  |  |  |  |  |  |
Organization and Description of Business (Details) [Line Items] |  |  |  |  |  |  |
Description of acquired entity | the Company acquired 4P Therapeutics LLC (“4P Therapeutics”) for $2,250,000, consisting of 250,000 shares of common stock, valued at $1,850,000, and $400,000, and a royalty of 6% on all revenue generated by the Company from the abuse deterrent intellectual property that had been developed by 4P Therapeutics payable to the former owner of 4P Therapeutics. The former owner of 4P Therapeutics has been a director of the Company since April 2018, when the Company entered into an agreement to acquire 4P Therapeutics. |  |  |  |  |  |
Active Intelligence LLC [Member] |  |  |  |  |  |  |
Organization and Description of Business (Details) [Line Items] |  |  |  |  |  |  |
Acquired percentage |  | 100.00% |  |  |  |  |
Minimum [Member] |  |  |  |  |  |  |
Organization and Description of Business (Details) [Line Items] |  |  |  |  |  |  |
Property plant and equipment useful life |  |  |  |  | 3 years |  |
Maximum [Member] |  |  |  |  |  |  |
Organization and Description of Business (Details) [Line Items] |  |  |  |  |  |  |
Property plant and equipment useful life |  |  |  |  | 10 years |  |

X
- Definition Acquired percentage. + References No definition available. + Details
Name: | ntrb_AcquiredPercentage
Namespace Prefix: | ntrb_
Data Type: | dtr:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division. + References No definition available. + Details
Name: | ntrb_ConcentrationRiskPercentage
Namespace Prefix: | ntrb_
Data Type: | dtr:percentItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | ntrb_OrganizationandDescriptionofBusinessDetailsLineItems
Namespace Prefix: | ntrb_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Property plant and equipment useful life. + References No definition available. + Details
Name: | ntrb_PropertyPlantAndEquipmentsUsefulLife
Namespace Prefix: | ntrb_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition With respect to a business combination completed during the period, this element provides a description of the business, other than the name, which may include the industry, size, products and other important information. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463 + Details
Name: | us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 20 -Section 50 -Paragraph 3 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 20 -Section 55 -Paragraph 10 -URI http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 10 -URI http://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611 Reference 4: http://www.xbrl.org/2003/role/exampleRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 20 -Section 55 -Paragraph 22 -URI http://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313 + Details
Name: | us-gaap_DerivativeLiabilities
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03(10)(1)) -URI http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 45 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975 Reference 3: http://www.xbrl.org/2003/role/exampleRef -Publisher FASB -Name Accounting Standards Codification -Topic 852 -SubTopic 10 -Section 55 -Paragraph 10 -URI http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 45 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266 + Details
Name: | us-gaap_Goodwill
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Per share or per unit amount of equity securities issued. + References No definition available. + Details
Name: | us-gaap_SharesIssuedPricePerShare
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257 + Details
Name: | us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | srt_MajorCustomersAxis=ntrb_ThreeCustomerMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_MajorCustomersAxis=ntrb_TwoCustomerMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_MajorCustomersAxis=ntrb_OneCustomerMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=ntrb_TherapeuticsLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=ntrb_ActiveIntelligenceLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MinimumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |